These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mercaptopropionylglycine: a progress in cystine stone therapy. Hautmann R, Terhorst B, Stuhlsatz HW, Lutzeyer W. J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714 [Abstract] [Full Text] [Related]
5. The effect of sodium intake on cystinuria with and without tiopronin treatment. Lindell A, Denneberg T, Edholm E, Jeppsson JO. Nephron; 1995 May; 71(4):407-15. PubMed ID: 8587620 [Abstract] [Full Text] [Related]
6. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. Pak CY, Fuller C, Sakhaee K, Zerwekh JE, Adams BV. J Urol; 1986 Nov; 136(5):1003-8. PubMed ID: 3534301 [Abstract] [Full Text] [Related]
7. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds. Fjellstedt E, Harnevik L, Jeppsson JO, Tiselius HG, Söderkvist P, Denneberg T. Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528 [Abstract] [Full Text] [Related]
8. Urinary excretion of free cystine and the tiopronin-cysteine-mixed disulfide during long term tiopronin treatment of cystinuria. Lindell A, Denneberg T, Jeppsson JO. Nephron; 1995 Dec; 71(3):328-42. PubMed ID: 8569983 [Abstract] [Full Text] [Related]
9. Sulfur amino acid metabolism in juvenile-onset nonketotic and ketotic diabetic patients. Mårtensson J, Hermansson G. Metabolism; 1984 May; 33(5):425-8. PubMed ID: 6425609 [Abstract] [Full Text] [Related]
10. 2-Mercaptopropionate, a novel metabolite formed during treatment with 2-mercaptopropionyl-glycine in cystinuria. Mårtensson J, Denneberg T, Kågedal B. Eur J Clin Pharmacol; 1986 May; 31(1):119-21. PubMed ID: 3780820 [Abstract] [Full Text] [Related]
12. Urinary excretion of metals during treatment with D-penicillamine and 2-mercaptopropionylglycine in normal and cystinuric dogs. Hoppe A, Denneberg T, Frank A, Kågedals B, Petersson LR. J Vet Pharmacol Ther; 1993 Mar; 16(1):93-102. PubMed ID: 8479006 [Abstract] [Full Text] [Related]
13. Urinary excretion of sulfur amino acids and sulfur metabolites in burned patients receiving parenteral nutrition. Larsson J, Liljedahl SO, Mårtensson J, Nordström H, Schildt B, Sörbo B. J Trauma; 1982 Aug; 22(8):656-63. PubMed ID: 6809955 [Abstract] [Full Text] [Related]
14. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. Dolin DJ, Asplin JR, Flagel L, Grasso M, Goldfarb DS. J Endourol; 2005 Apr; 19(3):429-32. PubMed ID: 15865542 [Abstract] [Full Text] [Related]
17. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis. Yu TF, Roboz J, Johnson S, Kaung C. J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720 [Abstract] [Full Text] [Related]
18. Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria. Malieckal DA, Modersitzki F, Mara K, Enders FT, Asplin JR, Goldfarb DS. Urolithiasis; 2019 Dec; 47(6):549-555. PubMed ID: 30980122 [Abstract] [Full Text] [Related]
19. Urinary excretion of amino acids in normal and cystinuric dogs. Hoppe A, Denneberg T, Jeppsson JO, Kågedal B. Br Vet J; 1993 Dec; 149(3):253-68. PubMed ID: 8334507 [Abstract] [Full Text] [Related]